Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Mechanical Circulatory Support for Right Ventricular Failure
Author(s): Ersilia M DeFilippis , Veli K Topkara , Ajay J Kirtane , et al Added: 1 year ago

Heart Failure
AHA 23: ECLS-SHOCK: Impact of Cardiac Arrest on the Efficacy of ECLS Patients
Author(s): Uwe Zeymer Added: 5 months ago
AHA 23 - We are joined on-site by Prof Uwe Zeymer (Klinikum Ludwigshafen, Ludwigshafen, DE) to discuss the findings from a sub-analysis of the ECLS-SHOCK trial.This sub-analysis investigates the impact of cardiac arrest before randomisation on the efficacy of ECLS in patients with infarct-related cardiogenic shock. Investigators enrolled 420 patients with acute MI and cardiogenic shock across 41… View more

Heart Failure

Prevention & Chronic Conditions
Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
Author(s): Aniket S Rali , Ahmed M Salem , Melat Gebre , et al Added: 3 years ago

Anticoagulation
Author(s): Till Hauffe , Bernard Krüger , Dominique Bettex , et al Added: 3 years ago
Shock in cardio-surgical intensive care unit (ICU) patients is a serious condition with a high morbidity and mortality.1,2 Prompt identification of the underlying conditions and correct management of the life- threatening physiological deteriorations are crucial to save the patient’s life. In daily practice, however, focusing on the main goal – to provide adequate oxygen delivery thereby… View more

Vascular Disease and Surgery

Heart Failure
Author(s): John Pepper Added: 3 years ago
The most common cause of heart failure with reduced ejection fraction (HFrEF) in the industrialised world is coronary heart disease.1 Patients with an ischaemic aetiology of left ventricular systolic dysfunction have significantly higher mortality rates than those with non-ischaemic aetiologies.2 This more aggressive course represents the convergence of ischaemic myocardial fibrosis and… View more

Vascular Disease and Surgery

Heart Failure
Vineet Agrawal
Research Area(s) / Expertise: Job title: Assistant Professor of Medicine
Personal History Dr Vineet Agrawal is a physician-scientist and is Assistant Professor of Medicine at the Vanderbilt University Medical Center. He is from Omaha, Nebraska.1, 2, 5 Academic History In 2006, Dr Agrawal completed his undergraduate training at Duke University in Biomedical and Electrical Engineering. In 2012, he completed his MD and PhD in the Medical Scientist Training… View more
Tips and Tricks in Imaging Your Patients With Valvular Heart Disease
Author(s): Philippe Pibarot , Patrizio Lancellotti , Jose Luis Zamorano , et al Start date: Jun 23, 2021

Imaging & Diagnostics

Heart Failure
Endpoints in Heart Failure Drug Development
Author(s): Aliza Hussain , Arunima Misra , Biykem Bozkurt Added: 2 years ago

Heart Failure
State of the Art Structural Interventions in Heart Failure
Author(s): Jeffrey Park , Hussam S Suradi Added: 3 years ago
Heart failure (HF) is a major national and international pandemic with a prevalence of more than 5.8 million in the US and over 26 million worldwide. It is the leading cause of hospitalisation and healthcare costs in the US and it accounts for more than 1 million hospitalisations annually. In the US, up to 25% of patients hospitalised with HF are readmitted within 30 days.1 The financial burden… View more

Vascular Disease and Surgery

Heart Failure
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more